JOARCA

Serial Number 90257576
606

Registration Progress

Application Filed
Oct 15, 2020
Under Examination
Dec 7, 2021
Approved for Publication
Oct 12, 2021
Published for Opposition
Oct 12, 2021
Registered

Basic Information

Serial Number
90257576
Filing Date
October 15, 2020
Published for Opposition
October 12, 2021
Abandonment Date
January 13, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 13, 2025
Classes
005

Rights Holder

Eagle Pharmaceuticals Inc.

03
Address
50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Ownership History

Eagle Pharmaceuticals Inc.

Original Applicant
03
Woodcliff Lake, NJ

Eagle Pharmaceuticals Inc.

Owner at Publication
03
Woodcliff Lake, NJ

Legal Representation

Attorney
John M. Mueller

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description
Jan 13, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 13, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
May 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2024 EX5G S SOU EXTENSION 5 GRANTED
May 10, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
May 10, 2024 EXT5 S SOU EXTENSION 5 FILED
Sep 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 28, 2023 EX4G S SOU EXTENSION 4 GRANTED
Sep 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 28, 2023 EXT4 S SOU EXTENSION 4 FILED
Jun 7, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 6, 2023 DOCK D ASSIGNED TO EXAMINER
Jun 5, 2023 EX3G S SOU EXTENSION 3 GRANTED
Jun 5, 2023 EXT3 S SOU EXTENSION 3 FILED
Jun 5, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2022 EX2G S SOU EXTENSION 2 GRANTED
Dec 7, 2022 EXT2 S SOU EXTENSION 2 FILED
Dec 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 8, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 6, 2022 EX1G S SOU EXTENSION 1 GRANTED
Jun 6, 2022 EXT1 S SOU EXTENSION 1 FILED
Jun 6, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 6, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 6, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 6, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 6, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 7, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 12, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 12, 2021 PUBO A PUBLISHED FOR OPPOSITION
Sep 22, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 3, 2021 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 3, 2021 GPRA F PRIORITY ACTION E-MAILED
Feb 3, 2021 CPRA R PRIORITY ACTION WRITTEN
Jan 27, 2021 DOCK D ASSIGNED TO EXAMINER
Dec 3, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of cancer

Classification

International Classes
005